Fundz

Sparrow Pharmaceuticals reported raising $61.8 Million in an initial SEC Form D filing, from an offering of $121 Million

PRIVATEJul 01, 2025

Amount Raised

$61.8 Million

$61.8 Million sold, per SEC Form D (first sale Jun 20, 2025)

Round Type

Venture

PortlandHealthcareHealth Care

Investors

ForbionRA Capital Management

Who to call at Sparrow Pharmaceuticals, and when

A new round usually means Sparrow Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sparrow Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sparrow Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sparrow Pharmaceuticals

Location

1050 Southwest 6th Street, Suite 1100

Portland, Oregon, United States

About

Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sparrow Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDavid K., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sparrow Pharmaceuticals's next move

See what Strategic adds

Sparrow Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.